Keio University To Research iPS Cells Of Alzheimer's Disease Patients
This article was originally published in PharmAsia News
Executive Summary
Keio University announced May 27 that it will start producing induced pluripotent stem cells from skin cells provided by patients with nervous system diseases such as Alzheimer's. The university will conduct research on the iPS cells in hopes of discovering the causes for the diseases and developing new therapeutic drugs. The team is also considering providing the iPS cells to other research facilities and companies to aid their new drug discovery effort. Besides AD, 25 other diseases are included in the research, such as Parkinson's disease, amyotrophic lateral sclerosis and retinal degeneration. (Click here for more - Japanese language
Keio University announced May 27 that it will start producing induced pluripotent stem cells from skin cells provided by patients with nervous system diseases such as Alzheimer's. The university will conduct research on the iPS cells in hopes of discovering the causes for the diseases and developing new therapeutic drugs. The team is also considering providing the iPS cells to other research facilities and companies to aid their new drug discovery effort. Besides AD, 25 other diseases are included in the research, such as Parkinson's disease, amyotrophic lateral sclerosis and retinal degeneration. (Click here for more - Japanese language)
|